Stocks and Investing Stocks and Investing
Wed, February 19, 2020

Benjamin Burnett Maintained (BLUE) at Hold with Decreased Target to $94 on, Feb 19th, 2020


Published on 2024-10-26 22:09:52 - WOPRAI, Benjamin Burnett
  Print publication without navigation


Benjamin Burnett of Stifel, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $96 to $94 on, Feb 19th, 2020.

Benjamin has made no other calls on BLUE in the last 4 months.



There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 1 agrees with Benjamin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $100 on, Friday, November 1st, 2019


These are the ratings of the 4 analyists that currently disagree with Benjamin


  • Joshua Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $100 on, Monday, February 3rd, 2020
  • Mark Breidenbach of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $135 on, Friday, December 13th, 2019
  • Yanan Zhu of "Wells Fargo" Maintained at Buy with Decreased Target to $160 on, Monday, December 9th, 2019
  • Mani Foroohar of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $119 on, Tuesday, November 26th, 2019
Contributing Sources